Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)
China · Delayed Price · Currency is CNY 8.78
+0.07 (0.80%)
Jul 30, 2026, 3:00 PM CST
Tibet Weixinkang Medicine Market Cap
Tibet Weixinkang Medicine has a market cap or net worth of 3.77 billion as of July 29, 2026. Its market cap has decreased by -33.92% in one year.
Market Cap
3.77B
Enterprise Value
2.72B
Revenue
1.16B
Ranking
n/a
PE Ratio
17.38
Stock Price
8.78
ChartMarket Cap Chart
Since July 21, 2017, Tibet Weixinkang Medicine's market cap has increased from 3.37B to 3.77B, an increase of 11.84%. That is a compound annual growth rate of 1.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.77B | -17.21% |
| Dec 31, 2025 | 4.55B | 5.04% |
| Dec 31, 2024 | 4.33B | -4.60% |
| Dec 29, 2023 | 4.54B | -34.48% |
| Dec 30, 2022 | 6.93B | 71.03% |
| Dec 31, 2021 | 4.05B | 6.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Newland Pharmaceutical | 3.83B |
| Tibet Duo Rui Pharmaceutical | 3.81B |
| Qianjiang Yongan Pharmaceutical | 3.77B |
| Sinotherapeutics | 3.75B |
| Jinhe Biotechnology CO., LTD. | 3.73B |
| Shanghai Jiaoda Onlly Co.,Ltd | 3.72B |
| Zhejiang Starry Pharmaceutical | 3.71B |
| Lionco Pharmaceutical Group | 3.66B |